Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...
Growing awareness of axial spondyloarthritis among the public is a key driver. Government-led initiatives, healthcare camps, and a focus on disease prevention contribute to heightened awareness, ...